Inovio Pharmaceuticals Inc (INO)

[Lakers_w]

5,901 participants of WHO Solidarity Trial already received first dose of COVID-19 vaccines — DOST

NationalNews
Charissa Luci-Atienza January 7, 2022
The Department of Science and Technology (DOST) said Friday, Jan. 7, that more than 5,900 participants of the World Health Organization’s (WHO) Solidarity Trial for Vaccines (STV) in the country have already received their first dose of vaccines against coronavirus disease (COVID-19).

(MANILA BULLETIN FILE)
DOST Undersecretary for Research and Development Dr. Rowena Cristina L. Guevara said as of Jan. 3, a total of 5,901 participants have been inoculated with the first dose of COVID-19 vaccine, while 3,840 participants have completed their two-dose regimen.

“As of January 3, 2022, eight hospitals and two community-based sites have already conducted the recruitment activities with a total of 5,901 have already been vaccinated with first dose and 3,840 participants have already completed the two-dose schedule of the first study vaccine,” she told the Manila Bulletin in an interview.

The lead investigators of the trial are Dr. Jodor A. Lim and Dr. Marissa M. Alejandria of the University of the Philippines (UP) Manila-Philippine General Hospital (PGH).

Guevara explained that the WHO-coordinated global study “Solidarity Trial Vaccines” is implemented locally through the project “Solidarity Vaccine Trial in the Philippines: Randomized Trial of Candidate Vaccines for COVID-19”.

She said recruitment of participants are ongoing on the following sites:

Philippine General Hospital (PGH)
Lung Center of the Philippines (LCP)
Makati Medical Center (MMC)
Quirino Memorial Medical Center (QMMC)
St. Luke’s Medical Center (SLCM)
Medical Center Manila (MCM)
Baguio General Hospital
San Juan De Dios Hospital (SJDH)
Sampaloc, Manila (community-based)
Crame, Quezon City (community-based)

The project team is eyeing to enroll 15,000 to 20,000 Filipinos aged 16 and above [40K worldwide in Mali, Colombia] to participate in the trial.
The enrolment of participants for the WHO STV started on Sept. 30, 2021.
Guevara said the study “will continue to run until the second quarter of 2022.”
https://mb.com.ph/2022/01/07/5901-participants-of-who-solidarity-trial-already-received-first-dose-of-covid-19-vaccines-dost/